Paul Tonko actually said...

"I think there is also an important distinction between access for the public and access for scholarships."

"This public policy area is a bit new to me so I am trying to get a better understanding of the interpretation of the NIH policy."

"At this point, I believe the language this Committee included in the reauthorization of the American Competes Act remains the best path forward."

"Thank you, Mr. Chair. And I want to thank all of our witnesses for coming today to testify before our subcommittee."